Viewing Study NCT03357159


Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2026-03-05 @ 1:33 AM
Study NCT ID: NCT03357159
Status: UNKNOWN
Last Update Posted: 2023-11-28
First Post: 2017-10-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti T-lymphocyte Immunoglobulin With Post Transplant Cyclophosphamide to Prevent GVHD Post Allogeneic Transplantation
Sponsor: Sheba Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Graft Versus Host Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None anti thymocyte globulin View
None cyclophospamide View
None graft-versus-host disease View
None stem cell transplantation View